ClinicalTrials.gg
Not yet recruitingNCT07800624Updated Sep 2, 2026

Does the Transversus Abdominis Plane(TAP) Block Effectively Manage Pain After Laparoscopic Cholecystectomy?

An interventional study of TAP Block in TAP Block and Cholecystectomy, Laparoscopic, sponsored by Jinnah Postgraduate Medical Centre. Not yet recruiting at 1 site in Pakistan. Open to participants aged 10 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Jinnah Postgraduate Medical Centre · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
10 Years to 60 Years
Sex
All
01

Study summary

The study is about managing pain after laparoscopic gallbladder surgery. Pain after surgery is very common and can affect recovery, delay normal activities, and increase the length of hospital stay. Poorly controlled pain can also increase the risk of developing long-term pain.

Good pain control can make patients more comfortable, reduce the need for opioid painkillers, shorten hospital stay, and improve patient satisfaction.

Laparoscopic cholecystectomy is a common surgery for gallstones. Although it is done through small cuts, patients can still experience significant pain after the operation. This pain can come from the surgical wounds, the abdominal organs, and pain felt in other areas.

A TAP block is a type of regional anesthesia that numbs the nerves supplying the abdominal wall. Previous studies have shown that TAP blocks may help reduce pain after surgery. However, there is limited research about its effectiveness in Pakistan and similar settings.

Therefore, this study will compare patients who undergo laparoscopic cholecystectomy with a TAP block to those who undergo the surgery without a TAP block. The study will assess their pain levels, how much pain medication they need, and how long they stay in the hospital.

The main aim is to determine whether using a TAP block can provide better pain control, reduce the need for painkillers, and shorten hospital stay after laparoscopic gallbladder surgery.

Read the detailed description

This study focuses on the management of pain after laparoscopic cholecystectomy, which is a common surgery performed to remove the gallbladder, usually because of symptomatic gallstones. Although laparoscopic surgery is less invasive than open surgery, patients can still experience significant pain after the procedure. This pain can affect their comfort, recovery, ability to move normally, and the time they need to remain in the hospital.

Postoperative pain is an important problem because poorly controlled acute pain can have both short-term and long-term effects. It may delay recovery, increase the need for painkillers, particularly opioids, and prolong hospital admission. In some patients, inadequately treated acute pain may also contribute to the development of chronic pain. Therefore, effective pain management is an important part of postoperative care.

Laparoscopic cholecystectomy is associated with different types of pain. The pain may come from the surgical incision sites, from the internal abdominal organs, or may be felt in another area of the body as referred pain. Because of these different sources, several methods have been used to control pain after surgery. These include conventional painkillers and different regional anesthesia techniques.

One of these techniques is the Transversus Abdominis Plane block, commonly called a TAP block. In this procedure, local anesthetic is injected into the plane between the abdominal muscles. The aim is to block the nerves that carry pain sensation from the abdominal wall. By reducing pain transmission, the TAP block may decrease the amount of pain experienced by the patient after surgery.

Previous studies have reported that TAP blocks can provide better postoperative pain control and may reduce the need for analgesic medications. However, most of the available evidence comes from studies conducted outside Pakistan. There is relatively limited local evidence about how effective and safe TAP blocks are in Pakistani patients undergoing laparoscopic cholecystectomy. Differences in patient characteristics, surgical techniques, anesthesia practices, and pain management protocols between countries make local research important.

This study is therefore designed to compare patients undergoing laparoscopic cholecystectomy with a TAP block to patients undergoing the same surgery without a TAP block. The researchers will assess whether the TAP block provides better postoperative pain control and reduces the need for additional pain medication.

The study will mainly assess three outcomes. The first is the patient's postoperative pain score, which will show whether patients receiving a TAP block experience less pain. The second is the amount of analgesic medication required after surgery, which will help determine whether the TAP block reduces the need for additional painkillers. The third is the length of hospital stay, which will show whether better pain control allows patients to recover and be discharged earlier.

Overall, the purpose of this study is to determine whether adding a TAP block to laparoscopic cholecystectomy can improve postoperative recovery. If the TAP block is found to significantly reduce pain, decrease analgesic requirements, and shorten hospital stay, it could support the use of TAP blocks as part of routine pain management for patients undergoing laparoscopic cholecystectomy in the local hospital setting.

02

Conditions studied

  • TAP Block
  • Cholecystectomy, Laparoscopic

Browse trials for

Keywords

  • TAP block
  • cholecystectomy, laparoscopic
  • post surgical pain
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's planned enrollment of 200 is above the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Jinnah Postgraduate Medical Centre is the lead sponsor of 38 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with symptomatic cholelithiasis and advised to undergo laparoscopic cholecystectomy.
  • Both Genders
  • Age more than 10 years and not above 60 years.

Exclusion criteria

Exclusion Criteria:

  • Patients with for surgery.
  • Patients below the age of 10 years or above 60 years.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Laparoscopic cholecystectomy with TAP Block

    Patients in this group will undergo laparoscopic cholecystectomy with a Transversus Abdominis Plane (TAP) block. The TAP block will be given as a regional anesthesia technique to reduce postoperative abdominal pain. Their postoperative pain will be assessed using the Visual Analogue Scale (VAS) at 0, 6, 12, 24, and 48 hours after surgery. Their analgesic requirements and length of hospital stay will also be recorded.

    Procedure: TAP Block

  • No intervention
    Laparoscopic cholecystectomy without TAP Block

    Patients in this group will undergo laparoscopic cholecystectomy without receiving a Transversus Abdominis Plane (TAP) block. They will receive the usual postoperative pain management provided as part of routine care. Their postoperative pain will be assessed using the Visual Analogue Scale (VAS) at 0, 6, 12, 24, and 48 hours after surgery. Their analgesic requirements and length of hospital stay will also be recorded.

Interventions

  • ProcedureTAP Block

    The intervention will consist of a Transversus Abdominis Plane (TAP) block performed in patients undergoing laparoscopic cholecystectomy. The TAP block will involve the injection of a local anesthetic into the plane between the abdominal muscles to block sensory nerves supplying the abdominal wall. It will be used to reduce postoperative pain and decrease the need for additional analgesic medication. Its effectiveness will be assessed by comparing postoperative pain scores, analgesic requirements, and length of hospital stay with patients who do not receive a TAP block.

    Also known as: Transverse abdominis plane block, Transversus abdominis plane block, Abdominal wall TAP Block

06

What researchers measure

Primary outcomes

  1. Postoperative pain score

    Pain will be measured using the Visual Analogue Scale (VAS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater postoperative pain (worse outcome).

    Time frame: At 0 (recovery room), 6, 12, 24, and 48 hours after surgery.

Secondary outcomes

  1. Length of hospital stay

    The duration of hospitalization after laparoscopic cholecystectomy will be measured and compared between patients who receive a TAP block and those who do not.

    Time frame: From the time of completion of surgery until hospital discharge, assessed continuously during the postoperative period up to 7 days after surgery or until discharge, whichever occurs first.

07

Study locations

1 site
  • Jinnah postgraduate medical university
    Karachi, Sindh 75500, Pakistan
08

References and documents

Publications

  • Zako J, Kevorkov A, Jeffries SD, Ramirez-Garcia Luna JL, Daccache N, Song K, Harutyunyan R, Ritchie C, Cafferty O, Laferriere-Langlois P, Hemmerling TM. Transversus abdominis plane block for postoperative pain management and opioid sparing: a systematic review and meta-analysis of randomised controlled trials. Br J Anaesth. 2026 Jan;136(1):266-282. doi: 10.1016/j.bja.2025.10.033. Epub 2025 Dec 2. PubMed 41339171 ↗
  • Atakan Ozkan, Nihat Gulaydin, Bahriye Kilic, Mert Mahsuni Sevinc. Is the application of subcostal transversus abdominis plane block effective for pain control in classical four-port laparoscopic aroscopic cholecystectomy?.Signa Vitae,2024,20(7):69-75 DOI:10.22514/sv.2024.076
  • Wang W, Wang L, Gao Y. A Meta-Analysis of Randomized Controlled Trials Concerning the Efficacy of Transversus Abdominis Plane Block for Pain Control After Laparoscopic Cholecystectomy. Front Surg. 2021 Aug 4;8:700318. doi: 10.3389/fsurg.2021.700318. eCollection 2021. PubMed 34422893 ↗
  • Osit LM, Gammad JJ, Flores OC (2021) The Efficacy of Ultrasound-Guided Bilateral Transversus Abdominal Plane (TAP) Block in Decreasing the Pain After Laparoscopic aroscopic Cholecystectomy : A Randomized Clinical Trial. J Med Res Surg 2(5): pp. 1-6. doi: 10.52916/jmrs214058
  • Park S, Park JH, Park S, Jang JN, Kim C, Choi YS. Ultrasound-guided subcostal approach of transversus abdominis plane block compared with wound infiltration for postoperative analgesia following laparoscopic cholecystectomy: A systematic review and meta-analysis. Medicine (Baltimore). 2024 May 3;103(18):e38044. doi: 10.1097/MD.0000000000038044. PubMed 38701299 ↗
  • Abraham S, Rivero HG, Erlikh IV, Griffith LF, Kondamudi VK. Surgical and nonsurgical management of gallstones. Am Fam Physician. 2014 May 15;89(10):795-802. PubMed 24866215 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07800624
Lead sponsor
Jinnah Postgraduate Medical Centre
Responsible party
Syeda Zareen Raza (Principal Investigator, Jinnah Postgraduate Medical Centre) — Principal investigator
First posted
Sep 2, 2026
Start date
Aug 30, 2026 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Sep 2, 2026

Study contacts

Zarreen Raza, MBBS, FCPS
Contact
zarreen.raza@jsmu.edu.pk
+92 3310324008

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion